1.85

5.71% 0.10

Health Catalyst Inc (HCAT)

Overview News Price History Option Chain Financials Discussions Forecast

Health Catalyst Inc stock is traded at $1.85, with a volume of 919.70K. It is up +5.71% in the last 24 hours and down -19.21% over the past month. Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Previous Close:

$1.75

Open:

$1.76

24h Volume:

919.70K

Relative Volume:

0.57

Market Cap:

$139.22M

Revenue:

$302.48M

Net Income/Loss:

$-265.26M

P/E Ratio:

-0.4978

EPS:

-3.716

Net Cash Flow:

$-2.76M

1W Performance:

+6.94%

1M Performance:

-19.21%

6M Performance:

+0.54%

1Y Performance:

-36.75%

1-Day Range:

$1.76

$1.885

1-Week Range:

$1.68

$1.885

52-Week Range:

$0.9551

$3.80

Health Catalyst Inc Stock (HCAT) Company Profile

Name

Health Catalyst Inc

Sector

Healthcare (1080)

Industry

Health Information Services (47)

Phone

801-708-6800

Address

10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN

Employee

1,200

Twitter

@HealthCatalyst

Next Earnings Date

2026-08-06

Latest SEC Filings

HCAT's Discussions on Twitter

Compare HCAT vs VEEV, BTSG, TEM, HQY, TXG

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HCAT Health Catalyst Inc	1.85	134.71M	302.48M	-265.26M	-2.76M	-3.716
VEEV Veeva Systems Inc	243.75	39.23B	3.32B	941.65M	1.64B	5.6161
BTSG Brightspring Health Services Inc	61.71	11.81B	13.65B	169.86M	412.12M	1.0758
TEM Tempus Ai Inc	52.10	9.85B	1.36B	-302.91M	-219.93M	-1.7182
HQY Healthequity Inc	104.73	8.82B	1.34B	230.70M	440.96M	2.6695
TXG 10 X Genomics Inc	56.09	7.52B	638.78M	-22.66M	122.18M	-0.1744

Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-18-26	Downgrade	Wells Fargo	Overweight → Equal Weight
Aug-27-25	Downgrade	Piper Sandler	Overweight → Neutral
Aug-11-25	Downgrade	Citigroup	Buy → Neutral
Aug-08-25	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jun-17-25	Downgrade	BTIG Research	Buy → Neutral
Apr-09-25	Downgrade	Evercore ISI	Outperform → In-line
Jan-08-25	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Apr-10-24	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Jan-03-24	Initiated	Barclays	Overweight
Jan-03-24	Upgrade	Evercore ISI	In-line → Outperform
Dec-13-23	Upgrade	JP Morgan	Neutral → Overweight
Nov-13-23	Upgrade	Piper Sandler	Neutral → Overweight
Aug-01-23	Initiated	Cantor Fitzgerald	Overweight
May-10-23	Downgrade	Guggenheim	Buy → Neutral
May-10-23	Downgrade	Raymond James	Outperform → Mkt Perform
Apr-20-23	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Apr-12-23	Initiated	Stephens	Equal-Weight
Apr-04-23	Upgrade	Wells Fargo	Equal Weight → Overweight
Jan-03-23	Downgrade	Evercore ISI	Outperform → In-line
Oct-31-22	Initiated	Wells Fargo	Equal Weight
Oct-25-22	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-13-22	Downgrade	Piper Sandler	Overweight → Neutral
Aug-05-22	Downgrade	JP Morgan	Overweight → Neutral
Aug-05-22	Downgrade	Stifel	Buy → Hold
Apr-14-22	Initiated	Guggenheim	Buy
Mar-17-22	Upgrade	Jefferies	Hold → Buy
Feb-11-22	Initiated	Goldman	Buy
Dec-02-21	Initiated	Jefferies	Hold
Oct-14-21	Initiated	BTIG Research	Buy
Apr-29-21	Resumed	JP Morgan	Overweight
Dec-08-20	Initiated	Berenberg	Buy
Jul-14-20	Initiated	Citigroup	Buy
Jun-18-20	Initiated	Stifel	Buy
Jun-15-20	Resumed	Evercore ISI	Outperform
May-15-20	Initiated	Guggenheim	Buy
Apr-21-20	Initiated	RBC Capital Mkts	Outperform
Apr-13-20	Initiated	SVB Leerink	Outperform
Apr-02-20	Initiated	Canaccord Genuity	Buy
Dec-20-19	Initiated	Raymond James	Strong Buy
Oct-30-19	Initiated	Cantor Fitzgerald	Overweight
Aug-19-19	Initiated	Evercore ISI	Outperform
Aug-19-19	Initiated	Goldman	Buy
Aug-19-19	Initiated	JP Morgan	Overweight
Aug-19-19	Initiated	Piper Jaffray	Overweight
Aug-19-19	Initiated	SVB Leerink	Outperform
Aug-19-19	Initiated	SunTrust	Buy
Aug-19-19	Initiated	William Blair	Outperform

View All

Health Catalyst Inc Stock (HCAT) Latest News

Aug 14, 2026

Health Catalyst (HCAT) group led by Clint Coghill reports 9.6% ownership stake - Stock Titan

Aug 14, 2026

Aug 13, 2026

Health Catalyst (HCAT) Q2 2026 Earnings Call Transcript - AOL.com

Aug 13, 2026

HCAT Maintains by Wells Fargo -- Price Target Lowered to $1.50 - GuruFocus

Aug 13, 2026

Wells Fargo & Company Has Lowered Expectations for Health Catalyst (NASDAQ:HCAT) Stock Price - MarketBeat

Aug 13, 2026

Aug 12, 2026

Health Catalyst, Inc. (NASDAQ:HCAT) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Aug 12, 2026

Aug 11, 2026

Health Catalyst: Q2 Earnings Snapshot - AOL.com

Aug 11, 2026

HCAT Maintained by Citigroup -- Price Target Lowered to $2.00 - GuruFocus

Aug 11, 2026

Health Catalyst (NASDAQ:HCAT) Price Target Cut to $2.00 by Analysts at Citigroup - MarketBeat

Aug 11, 2026

HCAT Q2 Deep Dive: Vitalware Divestiture Reshapes Strategy Amid Revenue Decline - Yahoo Finance

Aug 11, 2026